This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Fulcrum Sp Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2007-2015.
Location History:
- Rehovot, IL (2007)
- Rechovot, IL (2015)
Company Filing History:
2 out of 2 
2 out of 910 
Years Active: 2007-2015
Title: Arie Altman: Innovator in Polypeptide Research
Introduction
Arie Altman is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of polypeptide research, holding a total of 2 patents. His work focuses on the development of innovative polypeptides and their applications in various scientific fields.
Latest Patents
Altman's latest patents include advancements in Sp1 polypeptides and modified Sp1 polypeptides. These innovations involve the creation of SP1 and modified SP1 variant polypeptides that can form reversible molecular associations with various substances. Additionally, he has developed denaturant-stable and protease-resistant, chaperone-like oligomeric proteins. These proteins have applications in stabilizing, refolding, repairing, and preventing the aggregation of macromolecules such as proteins.
Career Highlights
Throughout his career, Arie Altman has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Fulcrum Sp Ltd. His research has significantly impacted the understanding and application of polypeptides in biotechnology and medicine.
Collaborations
Altman has collaborated with several professionals in his field, including Amnon Wolf and Ira Marton. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Arie Altman is a distinguished inventor whose work in polypeptide research has led to valuable innovations. His contributions continue to influence the scientific community and pave the way for future advancements in biotechnology.